J

Joincare Pharmaceutical Group Industry Co Ltd
SSE:600380

Watchlist Manager
Joincare Pharmaceutical Group Industry Co Ltd
SSE:600380
Watchlist
Price: 11.42 CNY 0.26% Market Closed
Market Cap: 21.4B CNY
Have any thoughts about
Joincare Pharmaceutical Group Industry Co Ltd?
Write Note

Joincare Pharmaceutical Group Industry Co Ltd
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Joincare Pharmaceutical Group Industry Co Ltd
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
J
Joincare Pharmaceutical Group Industry Co Ltd
SSE:600380
Intangible Assets
ÂĄ1.2B
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
10%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Intangible Assets
ÂĄ177.4m
CAGR 3-Years
162%
CAGR 5-Years
76%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Intangible Assets
ÂĄ279.1m
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
5%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Intangible Assets
ÂĄ4.2B
CAGR 3-Years
112%
CAGR 5-Years
64%
CAGR 10-Years
36%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Intangible Assets
ÂĄ593.5m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Intangible Assets
ÂĄ28m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joincare Pharmaceutical Group Industry Co Ltd
Glance View

Market Cap
21.4B CNY
Industry
Pharmaceuticals

Joincare Pharmaceutical Group Industry Co. Ltd., a noteworthy player in China's bustling pharmaceutical landscape, emerged as a beacon of innovation and resilience. With its roots stretching back to the mid-1990s, the company has consistently carved out a substantial niche in both the generic and proprietary drug markets. Its ability to synergistically blend cutting-edge research with cost-efficient production has been instrumental in ensuring its position as a formidable competitor. Joincare harnesses a robust pipeline of drugs targeting prevalent chronic diseases, complemented by its investment in high-growth biopharmaceuticals. From research and development to manufacturing and distribution, Joincare manages an integrated pharmaceutical supply chain that not only propels its profitability but also reinforces its mission to enhance public health. The company thrives on a diverse revenue model by leveraging both its proprietary products and a broad array of generic pharmaceuticals. It capitalizes on sustained demand for its products across domestic and international markets, ensuring a steady stream of income. By focusing on quality and affordability, Joincare has successfully navigated the complex regulatory landscape, earning certifications that open doors to global markets. This strategic emphasis on rigorous compliance not only mitigates risks but also builds trust with healthcare professionals and end-users alike. Through these efforts, Joincare continues to fortify its market position, all while contributing to the ever-evolving pharmaceutical industry with a pioneering spirit and an unwavering commitment to improving healthcare accessibility.

Intrinsic Value
18.96 CNY
Undervaluation 40%
Intrinsic Value
Price
J

See Also

What is Joincare Pharmaceutical Group Industry Co Ltd's Intangible Assets?
Intangible Assets
1.2B CNY

Based on the financial report for Sep 30, 2024, Joincare Pharmaceutical Group Industry Co Ltd's Intangible Assets amounts to 1.2B CNY.

What is Joincare Pharmaceutical Group Industry Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
10%

Over the last year, the Intangible Assets growth was 6%. The average annual Intangible Assets growth rates for Joincare Pharmaceutical Group Industry Co Ltd have been 9% over the past three years , 12% over the past five years , and 10% over the past ten years .

Back to Top